Emerging diseases

For some years, an increasing spread of new viruses and other pathogens has been observed. The diseases caused by these pathogenic agents are referred to as “emerging diseases”. This term refers to infectious diseases that either occur for the first time in a population or have increased rapidly in incidence and regional distribution.  

Emerging diseases pose a growing challenge for global health. Some influencing factors such as climate change, advancing urbanisation and increasing international mobility facilitate their spread. Besides known pathogens such as dengue, chikungunya and Zika virus, there are other pathogens that had been infrequent until now, which are becoming more and more important as they pose a significant risk for people.  

Early identification and continuous monitoring of these pathogens are crucial in order to develop effective strategies to prevent outbreaks. 


Products

Filter techniques:

Method
Parameter
Substrate
Species
IIFT
Bornavirus (BoDV)
infected and
uninfected cells
(2 BIOCHIPs per field)
EU 14
IIFT
Arbovirus Mosaic Australia 2
Murray Valley encephalitis virus (MVEV)
Ross River virus (RRV)
Barmah forest virus (BFV)
4 BIOCHIPs per field:
infected cells
infected cells
infected cells
non-infected cells

EU 14
EU 14
EU 14
EU 14
IIFT
Crimean Congo fever virus Mosaic 2
CCHFV-GPC
CCHFV-N
3 BIOCHIPs per field:
transfected cells
transfected cells
control transfection

EU 90
EU 90
EU 90
IIFT
Rift Valley fever virus (RVFV)
infected and non-
infected cells
(2 BIOCHIPs per field)
EU 14
IIFT
Venezuelan
equine encephalitis virus
(VEEV)
infected and non-
infected cells
(2 BIOCHIPs per field)
EU 14
IIFT
Sindbis virus (SINV)
infected and non-
infected cells
(2 BIOCHIPs per field)
EU 14
 *) For research use only, not for in vitro diagnostic use in the sense of EU directive 98/79/EG.
Back to top